DSGN
Design Therapeutics Inc
12.30$
-0.9%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | – | – | – | 100.0% | – | – | – | – | – | – | – | |
| – | 16.5% | – | – | – | 25.3% | – | – | – | – | – | – | – | |
| – | -16.5% | – | – | – | 50.0% | – | – | – | – | – | – | – | |
| – | 1,314.1% | – | – | – | 2,067.5% | – | – | – | – | – | – | – | |
| – | 490.3% | – | – | – | 771.6% | – | – | – | – | – | – | – | |
| – | 1,804.4% | – | – | – | 2,839.1% | – | – | – | – | – | – | – | |
| – | -1,804.4% | – | – | – | -2,839.1% | – | – | – | – | – | – | – | |
| – | 15.4% | – | – | – | – | – | – | – | – | – | – | – | |
| – | -1,413.1% | – | – | – | -2,321.6% | – | – | – | – | – | – | – | |
| – | 297.6% | – | – | – | – | – | – | – | – | – | – | – | |
| – | -1,413.1% | – | – | – | -2,321.6% | – | – | – | – | – | – | – | |
| – | -1,396.7% | – | – | – | -2,296.3% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.